Sorafenat 200mg – Affordable Nexavar Alternative for Kidney & Liver Cancer

Name: Sorafenat 200mg
Brand: Nexavar
SKU: 1934
Availability: InStock

Sorafenat 200 mg consists of medicinal ingredient contained in the Sorafenib. Sorafenib is a targeted therapy. It belongs to a group of medicines known as tyrosine kinase inhibitors. Sorafenib is also an angiogenesis inhibitor and VEGF inhibitor. It is an ant-cancer medicine used in the treatment of kidney, liver and differentiated thyroid cancer.

Precautions

What medications interact with Sorafenat?

Tell the doctor about the following medicines:

Coumadin
Rifampin
Phenobarbital
Indinavir
Paclitaxel
Digoxin
Warfarin
Dexamethasone
Carboplatin
Phenytoin
Irinotecan
Nefazodone
Carbamazepine
Nelfinavir
St. John's wort
Dexamethasone
Paclitaxel
Neomycin
5-fluorouracil

Do not take Sorafenib with above medicines as these can negatively interact with the drug and cause harm to your body. Also, inform your doctor, if you are taking any other medication other than Sorafenib.

When should Sorafenat not be used?

Before taking Sorafenat tell your physician, if you are allergic to the drug, or other tyrosine kinase inhibitors.
Inform your physician, if you have a history of kidney or liver problems.
Tell your physician, if you are on dialysis.
Inform your physician, if you have hemophilia.
Inform your physician, if you have a history of metabolic disorders.
Tell the physician, if you have high blood pressure, or heart disease.
Do not drive during the treatment with Sorafenib. You may experience dizziness while driving. Try not to involve in any motor activity.
Avoid taking Sorafenib, if you are pregnant, or plan to become pregnant. There is a need to risks and benefits of having Sorafenat tablets, during pregnancy.
Women who are breastfeeding, talk to your physician, before consuming Sorafenat tablets. It is possible that the medicine can pass into breast milk.

Dosage Instructions

How does Sorafenat work?

Sorafenat blocks the activity of an abnormal protein that signals malignant cells to divide and multiply. By doing this, it stops the spreading of malignant cells.

How should Sorafenat be taken?

The medicinal substance Sorafenat comes in the tablet form. Try to swallow the Sorafenat tablet with a glass of water.
The suggested dose of Sorafenib is 400 mg means 2 x 200 tablets twice each day.
Take the tablets as long as recommended by your doctor. Do not change the dosage plan. Take it exactly as your physician prescribed you.
Overdose: Immediately call the doctor, in the case of an overdose of Sorafenib. The overdose of Sorafenib may cause:

Rash or other skin problems
Diarrhea

Missed dose of Sorafenat:

In case, if you miss the dose, take it as soon as possible. If the time to take the next dose is near, leave the missed dose and take your next dose at the scheduled time.

Do not stop taking the medicine, without asking your doctor as stopping the intake of the drug may reverse your improving conditions.

How should Sorafenat be stored?

See the expiry date before taking the drug.
Keep the tablets reach out of children.
Try to keep the written records of all your medicines.
Do not give Sorafenat tablets to anyone, even if they have the same signs and symptoms.

Side Effects

What are Side effects of Sorafenat?

Some of the common adverse effects related to the administration of Sorafenat tablets are as follows:

Vision changes
Gastrointestinal bleeding
Bleeding from the respiratory tract
Hand foot syndrome
Weakness
Fever
Various skin problems
Hives
Infections
Blood and bone marrow problems
Muscle pain
Tiredness
Infections
Blood in vomit and coughs
Blood in the urine and stools
Metabolic problems
Sudden loss of weight
Diarrhoea
Dizziness
Extremely high BP (blood pressure)

Call the doctor right away, if you observe any of the side effects that are mentioned above.

How to Use

What is Sorafenat 200 mg used for?

The medicinal substance Sorafenat 200 mg is used for the treatment of:

Renal cell carcinoma
Hepatocellular carcinoma
Radioactive iodine resistant advanced thyroid carcinoma

Sorafenat 200 mg to treat your renal cell carcinoma, hepatocellular carcinoma and radioactive iodine resistant advanced thyroid carcinoma.

Infographics

FAQ

What is Sorafenib and what condition does it treat?

Sorafenib is a targeted cancer therapy classified as a kinase inhibitor used to treat specific types of advanced cancers. Sorafenat 200mg, containing sorafenib as its active ingredient, is prescribed primarily for hepatocellular carcinoma (liver cancer), renal cell carcinoma (kidney cancer), and differentiated thyroid cancer that has not responded to radioactive iodine treatment. This anticancer medication works by targeting cancer cells and their blood supply, slowing tumor growth and progression. Sorafenib belongs to a class of medications called multikinase inhibitors, which represent an important advancement in oncology treatment options for patients with these challenging malignancies.

How does Sorafenib work in the body?

Sorafenib functions through a dual-action mechanism that attacks cancer from two directions simultaneously. This kinase inhibitor blocks specific enzymes (protein kinases) that cancer cells need to multiply and survive, directly interfering with tumor cell growth. Additionally, Sorafenat 200mg inhibits angiogenesis—the formation of new blood vessels that tumors require for nutrients and oxygen. By cutting off the tumor's blood supply while simultaneously preventing cancer cell replication, this targeted therapy creates a hostile environment for malignant cells. Unlike traditional chemotherapy that affects all rapidly dividing cells, sorafenib specifically targets molecular pathways essential for cancer progression, making it a precision oncology treatment.

How long does Sorafenat 200mg take to work?

Sorafenat 200mg begins working at the cellular level within hours of administration, but measurable clinical responses typically take several weeks to become apparent. Most oncologists assess treatment effectiveness through imaging scans and tumor marker tests after 8-12 weeks of continuous sorafenib therapy. Some patients notice stabilization of their condition or symptom improvement within the first month, while others may require longer treatment periods before benefits become evident. This kinase inhibitor works progressively rather than providing immediate results, as it gradually restricts tumor growth and blood vessel formation. Response timelines vary significantly based on cancer type, disease stage, and individual patient factors affecting sorafenib metabolism.

When and how should I take Sorafenat 200mg?

Take Sorafenat 200mg exactly as prescribed by your oncologist, typically two tablets (400mg total) twice daily—morning and evening doses 12 hours apart. Swallow sorafenib tablets whole with water on an empty stomach, either one hour before meals or two hours after eating, as food significantly reduces absorption of this anticancer medication. Maintain consistent timing each day to optimize therapeutic levels. If you miss a dose and your next scheduled dose is within four hours, skip the missed tablet and resume your regular schedule. Never double doses of this kinase inhibitor. Your healthcare provider will adjust your dosing based on treatment response and any side effects experienced.

Is Sorafenat 200mg safe for long-term use?

Sorafenat 200mg is designed for continuous long-term administration in advanced cancer treatment, with many patients remaining on this kinase inhibitor for months or years under careful medical supervision. Oncologists regularly monitor liver function, kidney parameters, blood pressure, and blood counts throughout sorafenib therapy to ensure safe ongoing use. While this targeted cancer treatment is generally well-tolerated long-term compared to traditional chemotherapy, dose adjustments or temporary interruptions may be necessary based on individual tolerance and side effect management. The benefits of continued tumor control typically outweigh risks when properly monitored. Long-term safety profiles from clinical trials support extended sorafenib use for appropriate cancer patients.

Can I take Sorafenat 200mg with other medicines?

Sorafenat 200mg can interact with numerous medications, requiring careful pharmaceutical review before combining treatments. This kinase inhibitor interacts significantly with warfarin (increased bleeding risk), certain cardiac medications, antifungals, antibiotics, anticonvulsants, and herbal supplements like St. John's wort. Drugs that affect stomach acid (like omeprazole) may alter sorafenib absorption. Even common pain relievers and supplements require evaluation when taking this anticancer medication. Provide your oncologist and pharmacist with a complete list of all prescription medicines, over-the-counter products, vitamins, and herbal supplements you use. PremiumRxDrugs offers prescription management services to help coordinate your cancer therapy safely with other necessary medications.

How does Sorafenat 200mg compare to similar medicines in its class?

Sorafenat 200mg containing sorafenib was among the first oral multikinase inhibitors approved for liver and kidney cancers, establishing a benchmark in targeted oncology. Compared to similar kinase inhibitors like regorafenib, lenvatinib, or cabozantinib, sorafenib offers a well-established safety profile backed by extensive clinical data spanning over 15 years. While newer targeted therapies may demonstrate superior efficacy in specific patient subgroups, this anticancer medication remains a standard first-line treatment option due to its proven effectiveness, predictable side effect management, and broad clinical experience. Oncologists choose between these medications based on cancer type, disease progression, prior treatments, patient tolerance factors, and specific molecular characteristics of individual tumors.

Is the generic Sorafenib as effective as branded versions?

Generic sorafenib, including Sorafenat 200mg, demonstrates equivalent therapeutic effectiveness to branded versions like Nexavar when manufactured to regulatory standards. Pharmaceutical authorities in the USA, UK, Australia, and Canada require generic kinase inhibitors to meet stringent bioequivalence criteria—producing the same blood concentration levels and clinical outcomes as original branded medications. The active ingredient sorafenib remains chemically identical regardless of manufacturer; differences exist only in inactive excipients that don't affect anticancer activity. Generic versions offer substantial cost savings while delivering the same tumor-fighting benefits, making this targeted cancer therapy more accessible. Reputable pharmacies source generics from WHO-approved manufacturers maintaining quality standards equivalent to branded pharmaceutical producers.

Why do patients choose PremiumRxDrugs for Sorafenat 200mg?

Cancer patients select PremiumRxDrugs for Sorafenat 200mg due to meaningful cost savings on this expensive long-term kinase inhibitor therapy without compromising medication authenticity. Our competitive pricing makes continuous sorafenib treatment financially sustainable for patients facing extended cancer therapy needs. The pharmacy's easy reorder system simplifies ongoing medication management—particularly valuable when dealing with complex oncology treatment schedules. Discreet packaging respects patient privacy during sensitive cancer treatment periods. With free shipping options on international orders and reliable worldwide delivery, patients maintain uninterrupted access to this critical anticancer medication. Over ten years serving the global community has established PremiumRxDrugs as a trusted source where prescription verification and pharmaceutical quality remain uncompromised.

What are the common side effects of Sorafenib?

Common side effects of sorafenib include hand-foot skin reaction (redness, swelling, or peeling of palms and soles), diarrhea, fatigue, hair thinning or loss, reduced appetite, nausea, and rash. Many patients experience hypertension (high blood pressure) requiring monitoring and management. Other frequent effects include weight loss, voice hoarseness, and mouth sores. Most of these kinase inhibitor side effects are manageable with supportive care, dose adjustments, or temporary treatment interruptions. While generally milder than traditional chemotherapy effects, sorafenib's impact on skin and gastrointestinal function requires proactive management. Dermatological creams, dietary modifications, antidiarrheal medications, and blood pressure treatments help patients maintain quality of life during this targeted cancer therapy.

Who should avoid taking Sorafenib?

Patients with known hypersensitivity to sorafenib or any formulation components should avoid this kinase inhibitor entirely. Pregnant or breastfeeding women must not take sorafenib due to serious risks of birth defects and harm to developing infants; effective contraception is essential during treatment and for weeks afterward. Individuals with severe hepatic impairment beyond their underlying liver cancer, recent major surgeries, or uncontrolled bleeding disorders require careful evaluation before starting this anticancer medication. Patients with squamous cell lung cancer face increased bleeding risks with sorafenib therapy. Those taking certain interacting medications or with cardiovascular conditions may need alternative treatments. Comprehensive medical assessment by an oncologist determines suitability for this targeted cancer therapy.

SKU	1934
Generic For	Nexavar
Strength	200mg
Active Ingredient	Sorafenib

Sorafenat 200mg